FindTrial
Sign In

How effective is the Repetitive Transcranial Magnetic Stimulation (rTMS) in improving Daily Living, Behaviour and Cognitive ability of Parkinson disease Patients: A Randomized Controlled Trial

To study the effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Activities of Daily Living, Behavioral and Cognitive ability (A-B-C) of Parkinson disease Patients through a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021847
Enrollment
130
Registered
2019-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Repetitive Transcranial Magnetic Stimulation (rTMS): This intervention would include 2 seconds each pulse, using an intensity of 100% of motor threshold and 20 hz frequency at dorso lat

Sponsors

Department of Biotechnology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consenting Individual 2. Patients diagnosed with idopathic Parkinson disease (As per UK Brain Bank Criteria) 3. Ability to sustain rTMS procedure for 2 weeks time period. 3. All education levels 4. Urban and rural 5. Right/left handedness

Exclusion criteria

Exclusion criteria: • Those not consenting • Any history of major psychiatric illness • Acute head injury • Patients with severe Depression on BDI-II (>=29)

Design outcomes

Primary

MeasureTime frame
The effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cognition and Behavioural domains of Parkinson disease Patients.Timepoint: baseline 1 month 3 months 6 months—

Secondary

MeasureTime frame
Parkinson Disease- Quality of Life- 39Timepoint: Parkinson Disease- Quality of Life- 39—

Countries

India

Contacts

Public ContactDr Ashima Nehra

Division of Clinical Neuropsychology, Neurosciences Centre, AIIMS, New Delhi

ashimanwadhawan@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026